Cancer nanotechnology

Main Article Content

Swati C Jagdale
Tejas P Shah
Bhanudas S Kuchekar
Aniruddha R Chabukswar
Dhiraj T Baviskar


Cancer nanotechnology is the latest trend in cancer therapy. It helps the pharmacist to formulate the product with
maximum therapeutic value and minimum or negligible range side effects. Cancer is the disease in which the abnormal
cells are quite similar to the normal cell with just minute functional or genetic change. Thus, it is very hard to target the
abnormal cells by the conventional method of the drug delivery system. Nanotechnology is probably the only method that
can be used for site-specific action without causing the side effects by killing the normal cells. This review article describes
the possible way to exploit the nanotechnology to targeted drug therapy in cancer. The various methods used are: systemic
delivery systems, passive targeting, active targeting, intracellular delivery, subcellular localization, and nanoparticle drugs.
Different cancer detection techniques like carbon nanotubes, nanorods, and biosensors are also available. This review article
gives an idea about the possible potential of nanotechnology in drug delivery, drug targeting, and the diagnosis of cancer.


Download data is not yet available.

Article Details

How to Cite
Jagdale, S. C., Shah, T. P., Kuchekar, B. S., Chabukswar, A. R., & Baviskar, D. T. (2014). Cancer nanotechnology. Asian Journal of Pharmaceutics (AJP), 3(1).


Alivisatos A. Perspectives on the physical chemistry of semiconductor

nanocrystals. J Phys Chem 1996;100:13226-39.

Suntherland A. Quantum dots as luminescent probes in biological

systems. Curr Opin Solid State Mater Sci 2002;6:36-370.

Perez E. American Pharmaceutical Partners announces presentation of

Abraxane survival data. In: 22nd annual Miami Breast Cancer Conference;

Miami, FL: 2005.

Williams J, Lansdown R, Sweitzer R, Romanowski M, LaBell R,

Ramaswami R, et al. Nanoparticle drug delivery system for

intravenous delivery of topoisomerase inhibitors. J Control Release


Leroux JC, Allemann E, De Jaeghere F, Duelker E, Gurny R. Biodegradable

nanoparticles: From sustained release formulation to improved site

specific drug delivery. J Control Release 1996;30:339-50.

Ringdorf H. Structure and properties of pharmacologically active

polymers. J Polym Sci Symp 1975;51:135-53.

Chari RV. Targeted delivery of chemotherapeutics: Tumor-activated

prodrug therapy. Adv Drug Deliv Rev 1998;31:89-104.

Maeda H, Matsumura Y. Tumouritropic and lymphotropic principles of

macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989;6:193-210.

Ohtsuka N, Konno T, Miyauchi Y, Maeda H. Anticancer effects of arterial

administration of the anticancer agent SMANCS with lipiodol on

metastatic lymph nodes. Cancer 1987;59:1560-5.

Shenoy D, Little S, Langer R, Amiji M. Poly (ethylene oxide) - modified poly

(beta-amino ester) nanoparticles as a pH-sensitive system for tumourtargeted

delivery of hydrophobic drugs: part 2. In vivo distribution and

tumour localization studies. Pharm Res 2005;22:2107-14.

Shenoy D, Little S, Langer R, Amiji M. Poly (ethylene oxide) - modified

poly (beta-amino ester) nanoparticles as a pH-sensitive system for

tumour-targeted delivery of hydrophobic drugs, Part 1: In vitro

evaluations. Mol Pharm 2005;2:357-66.

Shenoy DB, Amiji MM. Poly (ethylene oxide)-modified poly

(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen

in breast cancer. Int J Pharm 2005;293:261-70.

Kommareddy S, Tiwari SB, Amiji MM. Long-circulating polymeric

nanovectors for tumour-selective gene delivery. Technol Cancer Res

Treat 2005;4:615-25.

Kaul G, Amiji M. Long-circulating poly(ethylene glycol)-modified gelatin

nanoparticles for intracellular delivery. Pharm Res 2002;19:1061-7.

Kaul G, Amiji M. Tumour-targeted gene delivery using poly (ethylene

glycol)-modified gelatin nanoparticles: In vitro and in vivo studies. Pharm

Res 2005;22:951-61.

Kaul G, Amiji M. Cellular interactions and in vitro DNA transfection

studies with poly (ethylene glycol)-modified gelatin nanoparticles.

J Pharm Sci 2005;94:184-98.

Kommareddy S, Amiji M. Preparation and evaluation of thiolmodified

gelatin nanoparticles for intracellular DNA delivery in response to

glutathione. Bioconjug Chem 2005;16:1423-32.

Kommareddy S, Amiji M. Poly (ethylene glycol)-modified thiolated

gelatin nanoparticles for glutathione-responsive intracellular DNA

delivery. Nanomedicine 2007;3:32-42.

Kommareddy S, Amiji M. Antiangiogenic gene therapy with systemically

administered sFlt-1 plasmid DNA in engineered gelatin-based

nanovectors. Cancer Gene Ther 2007;14:488-98.

Cegnar M, Kristl J, Kos J. Nanoscale polymer carriers to deliver

chemotherapeutic agents to tumours. Expert Opin Biol Ther


Wagner E. Programmed drug delivery: Nanosystems for tumour

targeting. Exp Opin Biol Ther 2007;7:587-93.

Farokhzad OC, Karp JM, Langer R. Nanoparticle-aptamer bioconjugates

for cancer targeting. Exp Opin Drug Deliv 2006;3:311-24.

Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB,

et al. Antibody targeting of long-circulating lipidic nanoparticles does

not increase tumour localization but does increase internalization in

animal models. Cancer Res 2006;66:6732-40.

Elbayoumi TA, Pabba S, Roby A, Torchilin VP. Anti-nucleosome

antibody-modified liposomes and lipid-core micelles for tumour

targeted delivery of therapeutic and diagnostic agents. J Liposome

Res 2007;17:1-14.

Gupta B, Torchilin VP. Monoclonal antibody 2C5-modified

doxorubicin-loaded liposomes with significantly enhanced therapeutic

activity against intracranial human brain U-87 MG tumour xenografts in

nude mice. Cancer Immunol Immunother 2007;56:1215-23.

Fishman ML, Cooke PH, Coffin DR. Nanostructure of native pectin sugar

acid gels visualized by atomic force microscopy. Biomacromolecules


Torchilin VP. Recent approaches to intracellular delivery of drugs and

DNA and organelle targeting. Annu Rev Biomed Eng 2006;8:343-75.

Gupta B, Torchilin VP. Transactivating transcriptional activator mediated

Drug Delivery. Expert Opin Drug Deliv 2006;3:177-90.

Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing:

A formulation approach for poorly-water-soluble compounds. Eur J

Pharm Sci 2003;18:113-20.

Fishman ML, Cooke PH, Coffin DR. Nanostructure of native pectin sugar

acid gels visualized by atomic force microscopy. Biomacromolecules


Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms

associated with altered intracellular distribution of anticancer agents.

Pharmacol Ther 2000;85:217-29.

Diaz JF, Strobe R, Engelborghs Y, Souto AA, Andreu JM. Molecular

recognition of Taxol by microtubules kinetics and thermodynamics

of binding of fluorescent Taxol derivatives to an exposed site. J Biol

Chem 2000;275:26265-76.

Nicolaou KC, Riemer C, Kerr MA, Rideout D, Wrasidlo W. Design,

synthesis and biological-activity of protaxols. Nature 1993;364:464-6.

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al.

Circulating tumor cells, disease progression and survival in metastatic

breast cancer. N Engl J Med 2004;351:781-91.

Ellis WJ, Pfitzenmaier J, Colli J, Arfman E, Lange PH, Vessella RL.

Detection and isolation of prostate cancer cells from peripheral blood

and bone marrow. Urology 2003;61: 277-81.

Nam JM, Stoeva SI, Mirkin CA. Bio-bar-code-based DNA detection with

PCR-like sensitivity. J Am Chem Soc 2004;126:5932-3.

Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based bio-bar codes for

the ultrasensitive detection of proteins. Science 2003;301:1884-6.

Wang WU, Chen C, Lin KH, Fang Y, Lieber CM. Label-free detection of

small-molecule-protein interactions by using nanowire nanosensors.

Proc Natl Acad Sci USA 2005;102:3208-12.

Cui Y, Wei Q, Park H, Lieber CM. Nanowire nanosensors for highly

sensitive and selective detection of biological and chemical species.

Science 2001;293:1289-92.

Hahm J, Lieber CM. Direct ultrasensitive electrical detection of DNA

and DNA sequence variations using nanowire nanosensors. Nano Lett


Zheng GF, Patolsky F, Cui Y, Wang WU, Lieber CM. Multiplexed

electrical detection of cancer markers with nanowire sensor arrays.

Nat Biotechnol 2005;23:1294-301.

Wong SS, Joselevich E, Woolley AT, Cheung CL, Lieber CM. Covalently

functionalized nanotubes as nanometre-sized probes in chemistry and

biology. Nature 1998;394:52-5.

Woolley AT, Guillemette C, Cheung CL, Housman DE, Lieber CM. Direct

haplotyping of kilobase-size DNA using carbon nanotube probes. Nat

Biotechnol 2000;18:760-63.

Wang Z, Liu J, Liang Q, Wang Y, Luo G. Carbon nanotube modified

electrodes for the simultaneous determination of dopamine and

ascorbic acid. Analyst 2002;127:653-58.

Wang J, Liu GD, Jan MR. Ultrasensitive electrical biosensing of proteins and DNA: Carbon-nanotube derived amplification of the recognition

and transduction events. J Am Chem Soc 2004;126:3010-1.

Torchilin VP, Levchenko TS, Lukyanov AN, Khaw BA, Klibanov AL,

Rammohan R, et al. P-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and

simple attachment of specific ligands, including monoclonal antibodies,

to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim

Biophys Acta 2001;1511:397-411.

Blume G, Cevc G, Crommelin MD, Bakker-Woudenberg IA, Kluft C,

Storm G. Specific targeting with poly (ethylene glycol)-modified

liposomes: coupling of homing devices to the ends of the polymeric

chains combines effective target binding with long circulation

times. Biochim Biophys Acta 1993;1149:180-4.

Avraham R, James J. Development of biosensors for cancer clinical

testing. Biosensors and Bioelectronics 2006;21:1851-8.